InvestorsHub Logo
Followers 19
Posts 4617
Boards Moderated 0
Alias Born 04/12/2017

Re: Investor2014 post# 392124

Tuesday, 12/13/2022 12:47:58 PM

Tuesday, December 13, 2022 12:47:58 PM

Post# of 469313
In agreement, but dont you think the TGD has bigger fish to fry now days?

Not saying one thing can stop the other, but even if expanded assess is being work on behind closed doors.

Is it worth the announcement now? Is that really what the market is in search for or what we should focus our limited resources on?

Maybe it was even dropped from the company's top priorities at the moment.

Not sure but seems logical to do so in my opinion.

Top priorities (for me): AD full data, Rett completion (Excellence), PDD Extensions data, PD trial initiation.

Re-using post: I know is from February is it not possible the FDA guided the same for expanded. Wait for Excellence for more safety data on Rett, just a guess to why not thus far.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News